menu
    • menu

    Company profile for PsyBio Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. 1. Discovered an efficient, patent-pending bacterial biosynthesis process for tryptamine production. 2. Developing a portfolio of tryptamine-derived, psychedelically inspired molecules. 3. Demonstrated the entourage effect of certain tryptamines in a laboratory-controll...
    PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues. 1. Discovered an efficient, patent-pending bacterial biosynthesis process for tryptamine production. 2. Developing a portfolio of tryptamine-derived, psychedelically inspired molecules. 3. Demonstrated the entourage effect of certain tryptamines in a laboratory-controlled environment. ​

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PsyBio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4400 West Sample Rd, Coconut Creek, FL 33073
    Telephone
    Telephone
    513-449-9585
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.psybiolife.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PsyBio Therapeutics Successfully Demonstrates Commercial Scale Manufacturing
    PsyBio Therapeutics Successfully Demonstrates Commercial Scale Manufacturing

    07 Oct 2021

    // YAHOO

    https://finance.yahoo.com/news/psybio-therapeutics-successfully-demonstrates-commercial-113000919.html#:~:text=PsyBio%20Therapeutics%20Successfully%20Demonstrates%20Commercial%20Scale%20Manufacturing%20Feasibility,-Thu%2C%20October%207&text=OXFORD%2C%20Ohio%20and%20COCONUT%20CREEK,CNW%2F%20%2D%20PsyBio%20Therapeutics%20Corp.&text=The%20Company%20expects%20to%20commence,the%20first%20quarter%20of%202022.

    YAHOO
    07 Oct 2021
    Share Share
    PsyBio Therapeutics Announces Pre-IND Application Request Has Been Submitted
    PsyBio Therapeutics Announces Pre-IND Application Request Has Been Submitted

    23 Sep 2021

    // NEWSWIRE

    https://www.newswire.ca/news-releases/psybio-therapeutics-announces-pre-ind-application-request-has-been-submitted-to-the-united-states-food-and-drug-administration-812931401.html

    NEWSWIRE
    23 Sep 2021
    Share Share
    PsyBio Therapeutics Reports Second Quarter 2021 Financial Results
    PsyBio Therapeutics Reports Second Quarter 2021 Financial Results

    30 Aug 2021

    // NEWSWIRE

    https://www.newswire.ca/news-releases/psybio-therapeutics-reports-second-quarter-2021-financial-results-and-provides-corporate-update-on-intellectual-property-and-clinical-development-milestones-874669172.html

    NEWSWIRE
    30 Aug 2021
    Share Share
    PsyBio Therapeutics Files Patent Application with USPTO
    PsyBio Therapeutics Files Patent Application with USPTO

    16 Aug 2021

    // NEWSWIRE

    https://www.newswire.ca/news-releases/psybio-therapeutics-files-patent-application-with-uspto-for-production-methods-of-methylated-trypatamines-and-associated-analogs-834817755.html

    NEWSWIRE
    16 Aug 2021
    Share Share
    PsyBio is Filing for Novel Genetic Optimization Pathways
    PsyBio is Filing for Novel Genetic Optimization Pathways

    12 May 2021

    // NEWSWIRE

    https://www.newswire.ca/news-releases/psybio-therapeutics-increases-intellectual-property-portfolio-with-filing-of-novel-genetic-optimization-pathways-for-psychedelic-medication-biosynthesis-877198514.html

    NEWSWIRE
    12 May 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search